Mefenamic Acid

Especificaciones

61-68-7Número CAS

200-513-1Número CE

2-(2,3-dimethylanilino)benzoic acidNombre IUPAC

C15H15NO2Fórmula química

241.28 g/molPeso molecular

mefenamic acid; 61-68-7; Ponstel; 2-[(2,3-dimethylphenyl)amino]benzoic acid; Mephenamic acid; 2-((2,3-Dimethylphenyl)amino)benzoic acid; Mephenaminic acid; Ponstan; Methenamic acid; Vialidon; Lysalgo; Tanston; Acide mefenamique; Mefenaminsaeure; CN-35355; N-2,3-Xylylanthranilic acid; Acido mefenamico; Mefenaminic Acid; INF-3355; CI-473; Acidum mefenamicum; INF 3355; N-(2,3-Xylyl)-2-aminobenzoic acid; N-(2,3-Dimethylphenyl)anthranilic acid; Gardan; DTXSID5023243; Anthranilic acid, N-2,3-xylyl-; 2-(2,3-dimethylphenylamino)benzoic acid; Benzoic acid, 2-[(2,3-dimethylphenyl)amino]-; CN 35355; NSC-94437; Benzoic acid, 2-((2,3-dimethylphenyl)amino)-; J2.344B; 2-Diphenylaminecarboxylic acid, 2',3'-dimethyl-; CHEBI:6717; M01AG01; Benzoic acid, 2-(2,3-dimethylphenyl)amino-; NSC94437; 367589PJ2C; DTXCID103243; Mefenamicacid; Mendys; Ponstan fte; Opustan 250; Opustan 500; Dysman-250; Dysman-500; Meflam 250; Meflam 500; RefChem:5988; 200-513-1; Acid, Mefenamic; Apo Mefenamic; Nu Mefenamic; PMS Mefenamic Acid; Mefacit; Parkemed; Coslan; Ponalar; Bonabol; Bafameritin-M; Tamany Bonsan; Mefenamate; Pontal; Ponstan forte; Bafhameritin-M; 2-(2,3-Dimethylanilino)benzoic acid; Mefenacid; Namphen; Mefanamic acid; Ponstil; Ponstyl; HL 1; N-(2,3-Xylyl)anthranilic acid; AGN-1255; CL 473; MFCD00051721; NSC 94437; CI 473; CHEMBL686; MLS000069709; CAS-61-68-7; NCGC00016278-07; SMR000058188; Mefenaminsaeure [German]; Ac. mefenamico [Italian]; in-M; Acide mefenamique [French]; Acide mefenamique [INN-French]; Acido mefenamico [INN-Spanish]; Acidum mefenamicum [INN-Latin]; 2-(2,3-Xylidino)benzoic Acid; HSDB 3115; SR-01000000216; EINECS 200-513-1; BRN 2216243; mefenamic-acid; UNII-367589PJ2C; Mefenamic acid CRS; Prestwick_506; Anthranilic acid, N-(2,3-xylyl)-; Spectrum_000174; CPD000058188; Opera_ID_542; Mefenamic acid [USAN:USP:INN:BAN:JAN]; Prestwick0_000054; Prestwick1_000054; Prestwick2_000054; Prestwick3_000054; Spectrum2_001941; Spectrum3_001082; Spectrum4_001235; Spectrum5_001341; M1782; Mefenamic acid (Standard); Anthranilic acid,3-xylyl-; Epitope ID:613441; cid_4044; SCHEMBL3544; MEFENAMIC ACID [MI]; Oprea1_193889; BSPBio_000207; BSPBio_002724; KBioGR_001730; KBioSS_000654; MEFENAMIC ACID [INN]; MEFENAMIC ACID [JAN]; MLS001074162; DivK1c_000298; MEFENAMIC ACID [HSDB]; MEFENAMIC ACID [USAN]; SPECTRUM1501103; SPBio_002001; SPBio_002128; MEFENAMIC ACID [VANDF]; BPBio1_000229; F0850-6853; GTPL2593; orb1310196; orb3025366; SGCUT00005; WLN: QVR BMR B1 C1; MEFENAMIC ACID [MART.]; MEFENAMIC ACID [USP-RS]; MEFENAMIC ACID [WHO-DD]; SCHEMBL29350572; SCHEMBL29355128; SCHEMBL29465887; HMS500O20; HY-B0574R; KBio1_000298; KBio2_000654; KBio2_003222; KBio2_005790; KBio3_001944; BRD8217; MSK7159; NINDS_000298; GLXC-07949; HMS1568K09; HMS1921D13; HMS2090B07; HMS2092B17; HMS2095K09; HMS2232P18; HMS3259M19; HMS3370K18; HMS3652A10; HMS3712K09; HMS3885O22; HMS5082M08; Pharmakon1600-01501103; Mefenamic acid (JP18/USP/INN); Mefenamic acid, analytical standard; ALBB-025759; BRD-8217; HY-B0574; to_000071; Tox21_110344; Tox21_301983; BBL003564; BDBM50134036; CCG-39434; EBC-03713; MEFENAMIC ACID [ORANGE BOOK]; MSK7159-100A; NSC757834; s4078; SBB056999; STK666691; MEFENAMIC ACID [EP MONOGRAPH]; AKOS001025551; AKOS002388313; Benzoic acid,3-dimethylphenyl)amino]-; MEFENAMIC ACID [USP MONOGRAPH]; MSK7159-1000A; Tox21_110344_1; DB00784; FM25038; NC00517; NSC-757834; IDI1_000298; SMP2_000141; 2-(2,3-Dimethylanilino)benzoic acid #; 2-(2,3-dimethylphenyl)aminobenzoic acid; NCGC00016278-01; NCGC00016278-02; NCGC00016278-03; NCGC00016278-04; NCGC00016278-05; NCGC00016278-06; NCGC00016278-10; NCGC00022393-03; NCGC00022393-04; NCGC00022393-05; NCGC00255401-01; AC-11160; AC-38318; AS-12677; ST086740; SY045797; SBI-0051636.P002; 2-(2,3-Dimethyl-phenylamino)-benzoic acid; 2-[(2,3-dimethylphenyl) amino]benzoic acid; 2-Diphenylaminecarboxylic acid,3'-dimethyl-; AB00052200; NS00000218; SW196700-3; UNM000001233403; EN300-16695; C02168; D00151; AB00052200-17; AB00052200_18; AB00052200_19; F079420; Mefenamic acid Solution in Acetonitrile, 100ug/mL; Q284321; Mefenamic acid Solution in Acetonitrile, 1000ug/mL; SR-01000000216-2; SR-01000000216-4; BRD-K92778217-001-06-1; BRD-K92778217-001-31-9; BRD-K92778217-001-32-7; Z56755828; 2-(2,3-Dimethyl-phenylamino)-benzoic acid(Mefenamic acid); Mefenamic Acid Working Standard (Secondary Reference Standard); Mefenamic acid, European Pharmacopoeia (EP) Reference Standard; Mefenamic acid, United States Pharmacopeia (USP) Reference Standard; InChI=1/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18Sinónimos